ECHELON-3 trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

ECHELON-3 trial

Feb 13, 2025, 06:52 | Drugs

FDA Approved Brentuximab Vedotin Combo for Relapsed/Refractory LBCL

On February 11, 2025, the FDA approved the use of brentuximab vedotin (Adcetris, Seagen Inc.,…

All: 1 Posts: 1 - 100

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

'

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

'

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

'

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023